Introduction
DNA methylation is an epigenetic mark that enables the regulation of gene expression and, thereby, diverse biological processes including embryonic development, genomic imprinting, DOI: 10.1002/mnfr.201800092 and aging. Aberrant DNA methylation patterns are implicated in multiple common diseases such as lung cancer, cardiovascular diseases, and metabolic disorders. [1] [2] [3] [4] [5] [6] This epigenetic mark involves the covalent addition of a methyl group from S-adenosyl-l-methionine (SAM), the universal methyl donor, to the C-5 position of cytosine bases by DNA methyltransferases (DNMTs). [7] SAM is generated via one-carbon metabolism comprising the folate and methionine cycles, which includes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate that is catalyzed by methylenetetrahydrofolate reductase (MTHFR). The most well-characterized polymorphism in MTHFR, substitution of cytosine by thymine at position 677 (C677T) in exon 4, leads to genotype and dose-dependent reduced activity of the enzyme, which causes increased homocysteine and decreased folate concentrations, and these are associated with higher risk for age-associated diseases such as diabetes, vascular disease, and Down syndrome. [8] [9] [10] Although MTFHR genotype has been associated with changes in DNA methylation pattern in some studies, [11] few effects were observed in a recent meta-analysis of pooled data from almost 10 000 individuals. [12] Nutrients and other food components can modify DNA methylation patterns [13] to modulate biological functions that influence health and aging. Higher intakes or status of several www.advancedsciencenews.com www.mnf-journal.com micronutrients participate in one-carbon metabolism, including folate, choline, betaine, methionine, vitamin B 6 , and vitamin B 12 , which contribute to SAM production are associated with increased DNA methylation. [14, 15] Other nutrients, including flavanols and (-)-epigallocatechin-3-gallate (EGCG), are competitive inhibitors of DNMTs through binding within the active site of the enzyme, [16] leading to decreased global DNA methylation. Many studies support the hypothesis that dietary compounds can modify DNA methylation patterns and influence the aging process. [17] An increasing body of evidence also suggests that the discrepancy between chronological age and DNA methylation age (DNAm age) that is an estimate of biological age determined by assessment of DNA methylation at 353 CpG sites across the genome [18] is associated with risk of age-related diseases such as diabetes, obesity, cancer, and cardiovascular disease. [19, 20] In this study, we investigated the effect of supplementation with folic acid + vitamin B 12 as a methyl donor and flavanols as DNMT inhibitors upon global DNA methylation profiles, including estimates of DNA m age, using publicly available Illumina Infinium 450K methylation datasets. We observed that DNAm age estimated by Horvath's model was altered by gender and MTHFR 677CC genotype following dietary intervention.
Experimental Section

Study Design
Publicly available Illumina Infinium 450K datasets were utilized from two separate dietary intervention studies. Ethical approval for the studies was granted by the institutional Medical Ethics Committee [21] and the Medical Ethical Committee of Maastricht University and Academic Hospital Maastricht. [22] In the first intervention study, 44 older participants (65-75 years of age) were randomized to supplementation with folic acid (400 µg d -1 ) and vitamin B 12 (500 µg d -1 ) for 2 years. DNA methylation profiles before and after the intervention was measured in blood by Illumina Infinium 450K microarray and the dataset was made available through the Gene Expression Omnibus (GSE74548). [21] MTHFR genotype was also available from the study. The second intervention study was a nonrandomized trial in which 13 non-obese, healthy male smokers (aged 30-60 years) were supplemented with monomeric and oligomeric flavanols (MOF; 200 µg d -1 ) for 8 weeks. No genotype data was available from this study. DNA methylation profiles before and after the intervention were measured in blood by Illumina Infinium 450K microarray and the dataset was made available through the Gene Expression Omnibus (GSE54690). [22] The characteristic of participants in both intervention studies are summarized in Table 1 . For comparison with the effects of MOF, a dataset of DNA methylation profiles was also utilized from a study in which primary acute myeloid leukemia (AML) cells were treated with low-dose decitabine (DAC) (GSE40870). [23] 
Data Analysis
Datasets normalized by the SWAN procedure were used for our analysis. [24] Since each intervention study was examined sepa- rately, the two data sets were not normalized together. Probes with detection p-value >0.05 were excluded, [21] [22] [23] sex chromosomes and SNP10 probes [25] were also excluded. The annotations for TSS200, TSS1500, 5 UTR, 3 UTR, first exon, and gene body were acquired from the Illumina annotation file. For all datasets, global DNA methylation was determined by calculating the average across all interrogated CpG sites, and also in genomic regions (CpG islands, shores, shelves, and open-sea areas) with characteristically different CpG density. DNA methylation age was calculated by the Horvath 'epigenetic clock' model using the online tool (https://dnamage.genetics.ucla.edu/), and methylation data for 353 CpG loci as described previously. [18] 
Statistics
The effects of folic acid + vitamin B 12 and of MOF on global DNA methylation were analyzed using paired-sample t-tests and ANOVA test. Both datasets were assessed for normality and revealed to be normally distributed, and therefore suitable for parametric testing (Table 1 , Supporting Information). Paired sample t-tests were used to identify significant changes in global DNA methylation following MOF treatment, and age acceleration residuals among women with the MTHFR 677CC genotype. Repeated measures ANOVA was used to identify significant changes in global DNA methylation, DNAm age, and age acceleration residuals of dietary interventions in relation to MTHFR genotype, gender, and CpG density. Pearson's correlation coefficient was used to compare DNA methylation before and after the interventions. All analyses were performed using the IBM SPSS statistical software (version 24); data are presented as mean ± SD, and p-values <0.05 were considered to be significant.
Results
Global DNA Methylation Changes by CpG Density Following Supplementation with Folic Acid + Vitamin B 12 or with MOF
Global DNA methylation was calculated as the mean beta value across all loci on the Illumina Infinium microarray after (Figure 2A) . Following dietary intervention, DNA methylation was altered in a supplementspecific manner (p = 0.01, repeated measures ANOVA). DNA methylation at north shelves decreased after MOF intervention ( β = −0.003 ± 0.00006), but increased after folic acid + vitamin B 12 supplementation ( β = 0.001± 0.00006; Figure 2B ). DNA methylation at CpG islands increased after folic acid + vitamin B 12 supplementation ( β = 0.003 ± 0.00001), but decreased following MOF intervention ( β = -0.014 ± 0.00007). However, these observed differences in DNA methylation change by genomic region were not statistically significant (p = 1.00).
Interestingly, we observed a similar pattern of greater decreases in DNA methylation at regions with lower CpG density in cells from AML patients following treatment with DAC, a DNA methyltransferase (DNMT) inhibitor ( Figure 2C ). The magnitude of change in DNA methylation was significantly greater with DAC treatment than with MOF supplementation (p < 0.001, repeated measures ANOVA) and displayed an interaction with genomic region (p = 0.01), but the patterns of change by genomic region were very highly correlated (R 2 = 0.99, p-value < 0.0001; Figure 2D ). The effect of dietary intervention upon DNA methylation age was assessed using Horvath's 'epigenetic clock' model, [18] for both intervention studies (Figure 3A and B) . We calculated age acceleration residuals, defined as the regression of DNAm age on chronological age. Age acceleration did not significantly change following the interventions: the difference between means were -0.337 ± 2.061 for MOF (p = 0.87) and -0.765 ± 1.435 for folic acid + vitamin B 12 (p = 0.60; Figure 3C and D). However, differential methylation at the 353 epigenetic clock loci was observed in an intervention-specific manner similar to that across the wider genome. Increased methylation was observed at the loci following folic acid + vitamin B 12 supplementation, while reduced methylation was observed following MOF supplementation (p = 0.01, repeated measures ANOVA). Similar effects were observed across all genomic regions, with no interaction between the form of dietary supplementation and CpG density (p = 0.76; Figure 3E ).
Change in DNA Methylation
DNA Methylation Age after Folic Acid + Vitamin B 12 Supplementations by Gender and MTHFR Genotype
We analyzed the age acceleration residual by gender and MTHFR genotype for participants in the folic acid + vitamin B 12 intervention study. Age acceleration residuals in females with the MTHFR 677CC genotype displayed the greatest change following dietary intervention ( residual = -2.70) in comparison to males with the same genotype ( residual = -0.75), and females and males with the 677TT genotype ( residual = 0.16 and 0.76, respectively; Figure 4) . While the influence of genotype (p = 0.16, repeated measures ANOVA), gender (p = 0.41), and their interaction (p = 0.67) upon response to intervention were not statistically significant across all participants, we observed a significant reduction in age acceleration solely among women with the MTHFR 677CC genotype (p = 0.04, paired sample t-test). Furthermore, interestingly, we observed that age acceleration in males with the MTHFR 677TT genotype was higher than those with the MTHFR 677CC at baseline ( mean = 6.014 ± 2.422) and this relationship was unaltered following intervention ( mean = 7.529 ± 2.864) (Figure 4 ).
Discussion
Several dietary factors modify epigenetic patterns. [13] These include vitamins that contribute to the production of the methyl www.advancedsciencenews.com www.mnf-journal.com donor SAM via one-carbon metabolism, e.g., polyphenols that inhibit of DNMT activity. Using publically available datasets, our study has demonstrated that supplementation with folic acid + vitamin B 12 alters global DNA methylation, with differential effects of intervention agents by genomic domain, MTHFR genotype, and gender.
We observed that supplementation with folic acid + vitamin B 12 increased global DNA methylation levels in individuals with the MTHFR 677CC but not the MTHFR 677TT genotype, and that this effect was greatest at CpG islands and shores that are characteristically CpG-dense regions. The T version of the MTHFR C677T polymorphism results in the substitution of an alanine residue with a valine, leading to a 50% reduction in enzymatic activity, and 10-20% of individuals in Western Europe and North America have the 677TT genotype. [26, 27] Observational studies have reported that higher levels of folic acid and vitamin B 12 in the diet are associated with higher global DNA methylation levels. [14, 15] However, contrary to our findings, Jung et al. [28] reported no significant effect of supplementation with 0.8 mg folic acid per day on global DNA methylation even when MTHFR genotype was taken into account. We speculate that this discrepancy may be due to differences in methodology used for quantifying global DNA methylation. Jung et al. used an LC-MS/MS approach that quantifies all methylated cytosines relative to total cytosine in the genome. In contrast, we used data from the Illumina Infinium DNA methylation microarray platform that interrogates more than 450 000 specific cytosine residues that are located predominantly in CpG-dense regions such as CpG islands that we observed were more susceptible to the effects of folic acid + vitamin B 12 .
The 'epigenetic clock' model developed by Horvath [18] provides estimates of DNAm age-a putative measure of biological age. This model integrates DNA methylation at 353 CpG sites that map to genes associated with cell survival and development and that may measure the cumulative effect of an epigenetic maintenance system. [18] Age acceleration, where the calculated DNAm age exceeds chronological age, has been observed in the liver of obese individuals, [20] is associated with the development of age-associated diseases such as Parkinson's disease [31] and coronary heart disease, [29] and has demonstrated links with allcause mortality in multiple studies. [19, 30, 31] Recent investigation of observational studies has shown that higher intakes of fish and vegetables are associated with reduced epigenetic aging using an enhanced version of an alternative model developed by Hannum et al. [32] Our study identified an association between dietary supplementation with folic acid + vitamin B 12 and decreased epigenetic aging, but only in women with the MTHFR 677CC genotype. Women might need less folate supplementation due to differences in body mass by gender, [33] and therefore higher doses of folate may be required to produce the same biological effect in men. This is supported by the finding that, following folic acid + vitamin B 12 intervention study, serum folate concentration was higher among women than men, and highest of all among women with the 677CC genotype (data not shown). We . Age acceleration residuals before and after MOF supplementation (C) and after folic acid + vitamin B 12 supplementation (D). E) DNA methylation changes at epigenetic clock loci by CpG density, with each data point corresponding to the average methylation change across the study participants for each of the 353 clock loci. Mean ± SD. *** p < 0.001; **** p < 0.0001. observed no significant correlation directly between age acceleration residuals and serum folate, serum vitamin B 12 , or plasma homocysteine levels (data not shown), thereby underlining the complex interaction among dietary intake, genotype, and epigenetic aging. Interestingly, our study also revealed significantly higher DNA methylation among men with the MTHFR 677TT genotype in comparison to those with the CC genotype irrespective of dietary intervention, but this was not the case among women. To the best of our knowledge, our observation of reduced epigenetic aging following folic acid + vitamin B 12 supplementation is the first reported effect of MTHFR genotype on DNA methylation in women, and may suggest that women with the more common 677CC genotype may benefit particularly from such supplementation. Notably, previous studies into genotype by gender interactions in response to folate have been conducted in populations with low folate intake, and we speculate that such gender and genotype effects may become apparent only when folate intake/status is higher. Further work is required to elucidate how MTHFR activity may influence the epigenetic aging process.
Indeed, there has recently been tremendous interest in the previously described epigenetic models of ageing, such as the 'epigenetic clock' model by Horvath, [18] that of Hannum et al., [34] and the age-associated epigenetic drift described by Teschendorff and colleagues. [35] Importantly, there is already substantial evidence to suggest that epigenetic ageing accelerates in response to lifestyles and exposures, such as tobacco smoke, [19] stress, [36] and obesity, [20] and also with outcomes such as all-cause mortality. [37] However, the changes in DNA methylation at the loci incorporated into these models are predominantly small in effect size. Furthermore, a recent study by Maegawa et al. [38] reported that [39] many epigenetic epidemiology studies have reported 1-5% changes in DNA methylation in response to environmental exposures, whether measuring gene-specific or global DNA methylation (frequently using LINE-1 and Alu as surrogate markers). In the context of epigenetic drift with aging, it can be interpreted that a 1% change in DNA methylation in response to environmental exposures is equivalent to 10 years' worth of natural epigenetic drift. Most environmental epigenetic studies utilize blood as the tissue in which to measure DNA methylation, and Issa has hypothesized that it could be possible to use epigenetic drift in blood as a surrogate for other tissues. [40] This, of course, would need to be examined carefully, and further work is required to establish how changes observed in blood may correlate with life expectancy. Nonetheless, there is sufficient evidence to support the hypothesis that small magnitude changes in DNA methylation, particularly when occurring at the pre-or postnatal stage, could be biologically significant in the context of representing epigenetic drift and the health consequences later in life.
Our study has limitations. First, the designs of the two independent intervention studies that we used differed in several respects including gender and age distribution of participants, and the duration of intervention. Because of this limitation, we chose to examine data from each independently, in parallel. Second, the number of participants receiving folic acid + vitamin B 12 supplementation was relatively small (n = 44) and so our observation of effects of gender and MTHFR genotype on DNA methylation patterns and on epigenetic age acceleration will need to be confirmed in future studies. In addition, it is likely that we did not have sufficient statistical power to detect other interactions. We therefore took steps to minimize potential sources of variability in order to maximize our potential to observe biological changes. The intervention studies used for our analysis were performed in healthy, non-obese individuals who were nonsmokers and did not drink alcohol excessively (folic acid + vitamin B12 intervention) or who were male smokers (MOF). The pairwise analysis of samples from participants before and after intervention enabled us to control for a number of potential confounding factors, and we stratified our analysis by gender, MTHFR genotype, and by use of age acceleration residuals, which are not correlated with chronological age.
In summary, for the first time, we report that supplementation with folic acid + vitamin B 12 or with monomeric and oligomeric flavanols can modify DNA methylation patterns and that these effects differ by intervention agent and by genomic location or CpG density. Further, the effect of folic acid + vitamin B 12 supplementation appear to be gender-and MTHFR genotype-specific. If confirmed in future independent studies, these novel findings will strengthen the evidence base for personalized nutrition strategies, which integrate genotypic data which may enhance the efficacy of dietary interventions. [41] Further work is required to determine the utility of these dietary compounds in the maintenance of normal epigenetic patterns for disease prevention.
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